An expert group is recommending Ontario clinicians ration doses of a drug used to treat COVID-19 as a supply shortage coincides with a third wave of infections that’s sending more patients into intensive care.
The scientists advising the province on the pandemic published revised clinical guidelines this week reflecting the shortage of tocilizumab, an anti-inflammatory drug approved in Canada to treat arthritis. A March report from the group found the drug reduced COVID-19 patients’ need for mechanical ventilation and improved chances of survival.
Eric Sorensen has more on the side effects of this drug decision.
For more info, please go to https://globalnews.ca/news/7746670/ontario-coronavirus-covid-drug-tocilizumab/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
The scientists advising the province on the pandemic published revised clinical guidelines this week reflecting the shortage of tocilizumab, an anti-inflammatory drug approved in Canada to treat arthritis. A March report from the group found the drug reduced COVID-19 patients’ need for mechanical ventilation and improved chances of survival.
Eric Sorensen has more on the side effects of this drug decision.
For more info, please go to https://globalnews.ca/news/7746670/ontario-coronavirus-covid-drug-tocilizumab/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
- Category
- U.S. & Canada
- Tags
- Canada, COVID-19, coronavirus
Sign in or sign up to post comments.
Be the first to comment